Today’s Research Reports on Trending Tickers: Omeros and Opko Health
NEW YORK, NY / ACCESSWIRE / March 2, 2018 / Markets continued to slide Thursday after President Trump announced that tariffs on steel and aluminum imports were on the way. The Dow Jones Industrial Average dropped 1.68 percent to close at 24,608.92, while the S&P 500 Index fell 1.33 percent to close at 2,677.67. The Nasdaq Composite Index declined 1.27 percent to close at 7,180.56. The President stated tariffs on imports would be 25 percent on steel and 10 percent on aluminum.
"That could really spook the market," said Marc Chaikin, CEO of Chaikin Analytics, according to CNBC. "The biggest wildcard would be a trade war and nobody should be excited for that."
RDI Initiates Coverage on:
Omeros Corporation
https://rdinvesting.com/news/?ticker=OMER
Opko Health, Inc.
https://rdinvesting.com/news/?ticker=OPK
Omeros' stock moved 2.67% lower Thursday, to close the day at $9.83. The stock recorded a trading volume of 1,324,275 shares, which was above its three months average volume of 894,310 shares. In the last year, Omeros' shares have traded in a range of 8.66 - 27.09. The stock is currently trading 63.71% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $14.71 is below its 200-day moving average of $18.36. Shares of Omeros have fallen roughly 39.21 percent in the past month and are down 49.41 percent year-to-date.
Access RDI's Omeros Corporation Research Report at:
https://rdinvesting.com/news/?ticker=OMER
On Thursday, shares of Opko Health recorded a trading volume of 7,712,007 shares, which was above the three months average volume of 4,405,551 shares. The stock ended the day 6.19% lower at 3.18. The stock is currently trading 62.76% below its 52 week high with a 52 week trading range of 3.16 - 8.54. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.27 is below its 200-day moving average of $5.51. Shares of Opko Health have fallen roughly 28.54 percent in the past month and are down 35.1 percent year-to-date.
Access RDI's Opko Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OPK
Our Actionable Research on Omeros Corporation (NASDAQ:OMER) and Opko Health, Inc. (NASDAQ:OPK) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
